Ep 146 [31 July 2024]: Craig Parzynski, Executive Director and Head of Biostatistics & Analytics at Genesis Research Group – We discussed major considerations in the use of RWD in RWE and for clinical trials. This was a conceptual conversation at the business leader level, with no expectation of biostatistical experience or expertise.
Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.